Supported Assets

Intellia Therapeutics

Soon

$10.00

-over selected period

$0.00 (0.00%)since US close

Onchain price
$10.00
Last close
$10.00Yahoo Finance ยท
Premium / discount
-

Price differences before fees and execution costs. Compare prices

Open Mo

About Intellia Therapeutics

Clinical-stage biopharmaceutical company developing potentially curative medicines using CRISPR gene editing and related technologies, including in vivo genome-editing candidates for hereditary angioedema and transthyretin amyloidosis.

Token

Token
NTLAc
Shares per token
1.00000000 NTLA